Astrocytes carrying the superoxide dismutase 1 (SOD1 G93A) mutation induce wild-type motor neuron degeneration in vivo

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 43, 2011, Pages 17803-17808

  Papadeas, Sophia T ^a   Kraig, Sarah E ^a   O'Banion, Colin ^a   Lepore, Angelo C ^a   Maragakis, Nicholas J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Neurodegeneration; Stem cells; Toxicity

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; SODIUM GLUCOSE COTRANSPORTER 1;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL ACTIVATION; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CERVICAL SPINAL CORD; CONTROLLED STUDY; FORELIMB; GENE MUTATION; GLIA CELL; IN VIVO STUDY; MICROGLIA; MOTONEURON; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY FAILURE; STEM CELL TRANSPLANTATION; UBIQUITINATION; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; CELL DEATH; CELL DIFFERENTIATION; EXCITATORY AMINO ACID TRANSPORTER 2; HUMANS; NERVE DEGENERATION; NEUROGLIA; POINT MUTATION; RATS; STEM CELL TRANSPLANTATION; SUPEROXIDE DISMUTASE; UBIQUITINATION;

ANIMALIA; RATTUS; RODENTIA;

EID: 80055074312     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1103141108     Document Type: Article

References (36)

1. Bruijn LI, Miller TM, Cleveland DW (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27:723-749. (Pubitemid 39050419)
2. Rosen DR, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62. (Pubitemid 23087289)
3. Turner BJ, Talbot K (2008) Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol 85:94-134.
4. Howland DS, et al. (2002) Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci USA 99:1604-1609. (Pubitemid 34136539)
5. Ilieva H, Polymenidou M, Cleveland DW (2009) Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 187:761-772.
6. Lobsiger CS, Cleveland DW (2007) Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 10:1355-1360. (Pubitemid 350014678)
7. Yamanaka K, et al. (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11:251-253. (Pubitemid 351311795)
8. Wang L, Gutmann DH, Roos RP (2011) Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Hum Mol Genet 20:286-293.
9. Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K (2007) Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 10:608-614. (Pubitemid 46652442)
10. Di Giorgio FP, Boulting GL, Bobrowicz S, Eggan KC (2008) Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3:637-648.
11. Nagai M, et al. (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10:615-622. (Pubitemid 46652435)
12. Marchetto MC, et al. (2008) Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3:649-657.
13. Mayer-Proschel M, Kalyani AJ, Mujtaba T, Rao MS (1997) Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells. Neuron 19:773-785. (Pubitemid 27471383)
14. Rao MS, Mayer-Proschel M (1997) Glial-restricted precursors are derived from multipotent neuroepithelial stem cells. Dev Biol 188:48-63. (Pubitemid 27360086)
15. Lepore AC, et al. (2008) Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 11:1294-1301.
16. Liu Y, et al. (2004) CD44 expression identifies astrocyte-restricted precursor cells. Dev Biol 276:31-46. (Pubitemid 39452844)
17. Bruijn LI, et al. (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327-338. (Pubitemid 27111114)
18. Wong PC, et al. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14:1105-1116.
19. Leigh PN, et al. (1991) Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 114:775-788.
20. Watanabe M, et al. (2001) Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol Dis 8:933-941. (Pubitemid 34017087)
21. Mackenzie IR, Neumann M, Cairns NJ, Munoz DG, Isaacs AM (2011) Novel types of frontotemporal lobar degeneration: Beyond tau and TDP-43. J Mol Neurosci, in press.
22. Lladó J, et al. (2006) Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS. Neurobiol Dis 21:110-118. (Pubitemid 41817311)
23. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38:73-84.
24. Ito D, et al. (1998) Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res 57:1-9. (Pubitemid 28279554)
25. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D (1996) Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci USA 93:14833-14838. (Pubitemid 26419055)
26. Gough PJ, Gordon S, Greaves DR (2001) The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo. Immunology 103:351-361. (Pubitemid 32626183)
27. Parwaresch MR, Radzun HJ, Kreipe H, Hansmann ML, Barth J (1986) Monocyte/macrophage-reactive monoclonal antibody Ki-M6 recognizes an intracytoplasmic antigen. Am J Pathol 125:141-151. (Pubitemid 17183767)
28. Zhu S, et al. (2002) Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417:74-78. (Pubitemid 34498818)
29. Van Den Bosch L, Tilkin P, Lemmens G, Robberecht W (2002) Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport 13:1067-1070. (Pubitemid 34587742)
30. Stirling DP, et al. (2004) Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 24:2182-2190. (Pubitemid 38314550)
31. Yrjänheikki J, et al. (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96:13496-13500.
32. Clement AM, et al. (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302:113-117. (Pubitemid 37210700)
33. Gong YH, Parsadanian AS, Andreeva A, Snider WD, Elliott JL (2000) Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J Neurosci 20:660-665. (Pubitemid 30225568)
34. Vargas MR, Johnson JA (2010) Astrogliosis in amyotrophic lateral sclerosis: Role and therapeutic potential of astrocytes. Neurotherapeutics 7:471-481.
35. Beers DR, et al. (2006) Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 103:16021-16026. (Pubitemid 44657585)
36. Kriz J, Nguyen MD, Julien JP (2002) Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 10:268-278. (Pubitemid 35217580)